NO20000284L - Garvesyre-polymerblandinger for kontrollert frigivelse av farmasøytiske midler, særlig i munnhulen - Google Patents

Garvesyre-polymerblandinger for kontrollert frigivelse av farmasøytiske midler, særlig i munnhulen

Info

Publication number
NO20000284L
NO20000284L NO20000284A NO20000284A NO20000284L NO 20000284 L NO20000284 L NO 20000284L NO 20000284 A NO20000284 A NO 20000284A NO 20000284 A NO20000284 A NO 20000284A NO 20000284 L NO20000284 L NO 20000284L
Authority
NO
Norway
Prior art keywords
tannic acid
controlled release
oral cavity
acid polymer
polymer compositions
Prior art date
Application number
NO20000284A
Other languages
English (en)
Other versions
NO20000284D0 (no
Inventor
E Itzhak Lerner
Vered Rosenberger
Moshe Flashner
Original Assignee
Perio Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perio Prod Ltd filed Critical Perio Prod Ltd
Publication of NO20000284D0 publication Critical patent/NO20000284D0/no
Publication of NO20000284L publication Critical patent/NO20000284L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører preparater med kontrollert eller vedvarende frigivelse, for frigivelse av farmasøytiske midler eller andre midler. Essensielle komponenter i preparatet ifølge oppfinnelsen inkluderer en eller flere polymerer og garvesyre eller tannin. Frigivelsen av det farmasøytiske middel eller annet middel er i en forhåndsbestemt tidsperiode og i en forhåndsbestemt konsentrasjon. Virkningsstedet for midlet er topisk, lokalt eller systemisk. Polymerene omfatter cellulose eller er proteinpolymerer.
NO20000284A 1997-07-23 2000-01-20 Garvesyre-polymerblandinger for kontrollert frigivelse av farmasøytiske midler, særlig i munnhulen NO20000284L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89912197A 1997-07-23 1997-07-23
PCT/US1998/015096 WO1999004764A1 (en) 1997-07-23 1998-07-22 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity

Publications (2)

Publication Number Publication Date
NO20000284D0 NO20000284D0 (no) 2000-01-20
NO20000284L true NO20000284L (no) 2000-03-22

Family

ID=25410514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000284A NO20000284L (no) 1997-07-23 2000-01-20 Garvesyre-polymerblandinger for kontrollert frigivelse av farmasøytiske midler, særlig i munnhulen

Country Status (10)

Country Link
EP (1) EP1003483A1 (no)
JP (1) JP2001510788A (no)
KR (1) KR20010021911A (no)
AU (1) AU8578498A (no)
BR (1) BR9811478A (no)
CA (1) CA2296654A1 (no)
HU (1) HUP0002490A2 (no)
IL (1) IL134151A0 (no)
NO (1) NO20000284L (no)
WO (1) WO1999004764A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674480B2 (en) 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US6476006B2 (en) 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US6881420B2 (en) 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
JP2004501190A (ja) * 2000-06-23 2004-01-15 テバ ファーマシューティカル インダストリーズ リミティド 治療薬の胃部保留および制御された放出のための急速膨張する組成物とその組成物を含む剤形
ES2288823T3 (es) * 2000-09-01 2008-02-01 Cognis Ip Management Gmbh Agente para cuidado bucal y dental.
JP4820024B2 (ja) * 2001-01-10 2011-11-24 昭和薬品化工株式会社 局所麻酔用組成物
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
EP1446167A4 (en) * 2001-11-05 2010-09-29 Orahealth Corp TREATMENT OF DISEASES WITH PATCHES TO INCREASE HEALING AND TREATMENT OF PAIN
CA2518329C (en) * 2003-03-12 2015-11-24 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
US20040185009A1 (en) * 2003-03-19 2004-09-23 Dexcel Pharma Technologies Ltd. Composition and device for treating periodontal diseases
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
WO2005048965A2 (en) * 2003-11-13 2005-06-02 Wm. Wrigley Jr. Company Method and composition for breath freshening
CN1997356A (zh) * 2004-04-23 2007-07-11 安姆根有限公司 持续释放制剂
US20100247653A1 (en) * 2006-04-11 2010-09-30 Hans Lautenschlager Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
US8642088B2 (en) 2009-09-04 2014-02-04 Wisconsin Alumni Research Foundation Tannin-chitosan composites
KR101307367B1 (ko) 2010-09-14 2013-09-25 주식회사 이노테라피 탄닌, 폴리에틸렌글리콜 및 물, 저급 알코올 또는 이들의 혼합물을 포함하는 접착제 조성물
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants
GB2496654A (en) * 2011-11-18 2013-05-22 Reckitt & Colman Overseas Self-assembling peptides
US20130158132A1 (en) * 2011-12-19 2013-06-20 Aida Salatinjants Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
WO2015167257A1 (ko) * 2014-04-29 2015-11-05 포항공과대학교 산학협력단 구강 도포용 조성물 및 그 제조 방법
RU2606589C2 (ru) * 2015-02-16 2017-01-10 Александр Александрович Кролевец Способ получения нанокапсул танина
US10532046B2 (en) * 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
CA3146610A1 (en) * 2019-08-16 2021-02-25 Adel Penhasi Adhesive drug delivery microparticles and a product comprising thereof
CN115477920A (zh) * 2021-06-15 2022-12-16 西南大学 一种单宁酸基水下粘合剂制备方法及制品
KR20230146888A (ko) 2022-04-13 2023-10-20 경북대학교 산학협력단 치아 수복을 위한 약물 서방성 자가 치유 코팅층 및 이의 제조방법
CN117322671A (zh) * 2023-11-01 2024-01-02 东莞市吉纯生物技术有限公司 一种烟碱脂质体及其制备方法与电子雾化液

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB104609A (en) * 1916-06-05 1917-03-15 Monneron & Guye A Method of Manufacturing a Medicinal Aluminium Preparation.
GB918754A (en) * 1959-08-14 1963-02-20 Armour & Co Improvements in or relating to corticotrophin preparations
GB2036750B (en) * 1978-11-23 1983-05-05 Payne M Tannin complexes
JPS5846011A (ja) * 1981-09-14 1983-03-17 Kao Corp 毛髪処理剤
JPH01166763A (ja) * 1987-12-22 1989-06-30 Nitta Gelatin Inc 医科用および歯科用硬化性材料
AU2252388A (en) * 1988-05-02 1989-11-29 Zila Pharmaceuticals Compositions and in situ methods for forming films on body tissue
JPH04114655A (ja) * 1990-09-03 1992-04-15 Shinonaga Kasei Kk 医療用硬化組成物
JPH04312522A (ja) * 1991-04-08 1992-11-04 Yoshiaki Kawashima 徐放性錠剤の製造方法
JP3496727B2 (ja) * 1993-12-27 2004-02-16 救急薬品工業株式会社 製剤用基剤
JPH08319232A (ja) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd 粉粒状組成物
JP2885668B2 (ja) * 1995-09-29 1999-04-26 沢井製薬株式会社 テプレノン製剤

Also Published As

Publication number Publication date
BR9811478A (pt) 2000-08-15
CA2296654A1 (en) 1999-02-04
AU8578498A (en) 1999-02-16
KR20010021911A (ko) 2001-03-15
JP2001510788A (ja) 2001-08-07
NO20000284D0 (no) 2000-01-20
HUP0002490A2 (hu) 2000-12-28
WO1999004764A1 (en) 1999-02-04
IL134151A0 (en) 2001-04-30
EP1003483A1 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
NO20000284L (no) Garvesyre-polymerblandinger for kontrollert frigivelse av farmasøytiske midler, særlig i munnhulen
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
HUP0004924A2 (hu) Ciklodextrineket tartalmazó gyógyászati készítmények
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
TR200102314T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
DE69033994D1 (de) Flüssige Polymerzusammensetzung und Verfahren zu ihrer Verwendung
KR950702409A (ko) 방출 조절 모르핀 제제(controlled release morphine preparation)
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DK0915898T3 (da) Krystalform I af clarithromycin
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
PL346764A1 (en) New oral formulation for 5-ht4
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
ATE201823T1 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia
ATE215941T1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE241640T1 (de) Fusidinsäure-derivate
ES2084747T3 (es) Polimeros en emulsion liberados de emulsionantes en preparados farmaceuticos con liberacion retardada de la sustancia activa, y su preparacion.
IT1213568B (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application